medigraphic.com
ISSN 2539-0859 (Electronic)
ISSN 0120-8411 (Print)
Asociación Colombiana de Otorrinolaringología y Cirugía de Cabeza y cuello, Maxilofacial y Estética Facial (ACORL)

2020, Number 4

<< Back Next >>

Acta de Otorrinolaringología CCC 2020; 48 (4)

Characterization of the otorrinolaringological manifestations in patients with HIV/AIDS infection in the city of Cartagena

Hortúa BAF, Montero CJ, Oñate CCS, Vásquez CC, Cuadrado CB

Language: Spanish
References: 26
Page: 283-290
PDF size: 357.54 Kb.


ABSTRACT

Introduction: In Colombia, the incidence of the disease has been increasing and Cartagena has the highest numbers of the country. Otorhinolaryngological manifestations in people with HIV/AIDS are estimated between 20%-80% generating a great impact on quality of life. Objective: To determine the epidemiological characteristics and otorhinolaryngological manifestations in a group of people with HIV / AIDS in the city of Cartagena. Methodology: Observational, descriptive, cross-sectional and prospective design. Information was collected from patients with HIV from the city of Cartagena who attended 2 medical centers, a questionnaire was applied to obtain epidemiological data, otorhinolaryngological signs and symptoms, as well as a complete otorhinolaryngological physical examination. Results: 150 patients were included in the study, with a mean age of 31 years, 59.3% male and 40.7% female. The most frequent non-otorhinolaryngological pathological antecedent was syphilis coinfection in 10% and otorhinolaryngological, sinusitis and oral candidiasis each with 3.3%. 73% of the patients at the time of the evaluation manifested otorhinolaryngological alteration, the otological ones being the most frequent with 39.9% of the patients. Furthermore, a significant relationship was observed between CD4 counts and findings such as laryngeal dysphonia (p = 0.045). Conclusions: The otological manifestations were the most frequent in our environment and a relationship was found between the CD4 count and the laryngeal manifestations of the disease.


REFERENCES

  1. Teva I, Bermúdez MP, Ramiro MT, Buela-Casal G. Currentepidemiological situation of HIV/AIDS in Latin America:analysis of differences among countries. Rev Med Chil. 2012;140(1):50-8.

  2. Instituto Nacional de Salud. Comportamiento del VIH/SIDAColombia, semana epidemiológica 47 (18 al 24 de noviembrede 2018). Boletín epidemiológico semanal 2018.

  3. El Howati A, Tappuni A. Systematic review of the changingpattern of the oral manifestations of HIV. J Investig Clin Dent.2018;9(4):e12351.

  4. Patton LL. Progress in understanding oral health and HIV/AIDS. Oral Dis. 2014;20(3):223-5.

  5. Leao JC, Ribeiro CMB, Carvalho AAT, Frezzini C, Porter S. Oralcomplications of HIV disease. Clinics. 2009;64(5):459-70.

  6. Tshifularo M, Govender L, Monama G. Otolaryngological andhead and neck manifestations in HIV-infected patients seen atSteve Biko Academic Hospital in Pretoria, South Africa. SouthAfrican Med J. 2013;103(7):464-6.

  7. Kirti YK, Yashveer JK, Poorey VK. Changing Trends of HIV/AIDS in Otorhinolaryngology with CD4+ Count Correlation.Indian J Otolaryngol Head Neck Surg. 2014;67(1):12-5.

  8. Iacovou E, Vlastarakos P V., Papacharalampous G, KampessisG, Nikolopoulos TP. Diagnosis and treatment of HIV-associatedmanifestations in otolaryngology. Infect Dis Rep. 2012;4(1):9.

  9. Prasad HK, Bhojwani KM, Shenoy V PS. HIV manifestationsin otolaryngology. Am J Otolaryngol. 2006;27(1–3):179-94.

  10. Lalwani A SC. Otologic and neurotologic manifestations ofacquired-immunodeficiency-syndrome. Otolaryngol ClinNorth Am. 1992;25(6):1183-97.

  11. Yamini Y, Mandelia C, Sreedharan S. Otorhinolaryngologicalmanifestations among HIV positive children in coastalKarnataka. J Clin Diagnostic Res. 2015;9(3).

  12. Fasunla AJ, Daniel A, Nwankwo U, Kuti KM, Nwaorgu OG,Akinyinka OO. Evaluation of Olfactory and Gustatory Functionof HIV Infected Women. AIDS Res Treat. 2016;2016:2045383.

  13. Gaurav S, Keerthilatha PM, Archna N. Prevalence of oralmanifestations and their association with CD4/CD8 ratio andHIV viral load in South India. Int J Dent. 2011;2011:964278.

  14. Lourenço AG, Motta ACF, Figueiredo LTM d., Machado AA,Komesu MC. Oral lesions associated with HIV infection beforeand during the antiretroviral therapy era in Ribeirão Preto,Brazil. J Oral Sci. 2011;53(3):37985.

  15. Neil Hamilton Wood AM. HIV-Associated Oral Lesions inHIV-Seropositive Patients at an HIVTreatment Clinic in SouthAfrica. J AIDS Clin Res. 2015;6(2).

  16. Mary EO, Abiola OA, Titilola G, Mojirayo OO, SulaimonAA. Prevalence of HIV related oral lesions in people livingwith HIV and on combined antiretroviral therapy: A Nigerianexperience. Pan Afr Med J. 2018;31:1-10.

  17. Bakhshaee M, Sarvghad MR, Khazaeni K, Movahed R,Hoseinpour AM. HIV: An epidemiologic study on head andneck involvement in 50 patients. Iran J Otorhinolaryngol.2014;26(75):97-103.

  18. Dompreh A. Lesions de l’ oreille, du nez et de la gorge chezles patients infectes par le VIH/SIDA au centre ospitalieruniversitaire d’ komfo anoky subvention de soutien: aucune. JWest African Coll Surg. 2012;2(2):1-16.

  19. Jafari S, Razmpa E, Saeedinejad Z, Sadrhosseini M, PaydaryK, Saedi B, et al. Otolaryngological manifestations in HIVinfected patients, Tehran, Iran. J AIDS Clin Res. 2012;3(6):3-6.

  20. Jiménez Malagón MC, Harris Ricardo J, Palomino Rossi W,Díaz Caballero AJ, del Río EP. Manifestaciones orales enpacientes VIH/SIDA asociadas a tratamiento antirretroviraly el estado inmunológico en dos fundaciones de la ciudad deCartagena. Av Odontoestomatol. 2012;28(4):181-9.

  21. Sulyman AB, Kazeem SA, Abdulrahman A, David D, KayodeAS, Oluwayemisi O, et al. Otolaryngologic manifestationsamong HIV/AIDS patients in a Nigerian tertiary healthinstitution: an update. Arq Int Otorrinolaringol. 2010;14(4):398-403.

  22. Torre P, Hoffman HJ, Springer G, Cox C, Young M, MargolickJB, et al. Cochlear function among HIV-seropositive and HIVseronegativemen and women. Ear Hear. 2014;35(1):56-62.

  23. Ranganathan K, Umadevi M, Saraswathi TR, Kumarasamy N,Solomon S, Johnson N. Oral lesions and conditions associatedwith human immunodeficiency virus infection in 1000South Indian patients. Ann Acad Med Singapore. 2004;33(4Suppl.):37-42.

  24. Tappuni AR, Fleming GJP. The effect of antiretroviral therapyon the prevalence of oral manifestations in HIV-infectedpatients: A UK study. Oral Surg Oral Med Oral Pathol OralRadiol Endod. 2001;92(6):623-8.

  25. Cortes J, Moreno A, Alvarez C, Tamara J. Experience withlopinavir/ritonavir for patients with HIV infection at anuniversity hospital in Bogotá, Colom. Infectio. 2006;10(4):220-5.

  26. Bravo IM, Correnti M, Escalona L, Perrone M, Brito A,Tovar V, et al. Prevalencia de lesiones bucales en pacientesVIH+, relación con contaje de células CD4+ y carga viral enuna población venezolana. Med Oral Patol Oral Cir Bucal.2006;11(1):25-31.




2020     |     www.medigraphic.com